Tyrosine Phosphorylation of Caspase-8 Abrogates Its Apoptotic Activity and Promotes Activation of c-Src
暂无分享,去创建一个
J. Marshall | E. Charbonney | J. Parodo | A. Kapus | K. Szászi | S. Jia | M. Lodyga | P. Plant | J. Tsang | Jennifer L.Y. Tsang | J. Marshall
[1] Doris Berger. The hunting of the src , 2014, Im Focus Onkologie.
[2] D. Stupack,et al. Rab5 Mediates Caspase-8–promoted Cell Motility and Metastasis , 2010, Molecular biology of the cell.
[3] K. Vuori,et al. Caspase-8 as a potential mediator of pro-tumorigenic signals , 2009, Cell cycle.
[4] M. Butterworth,et al. Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. , 2009, Molecular cell.
[5] K. Vuori,et al. Critical role for caspase-8 in epidermal growth factor signaling. , 2009, Cancer research.
[6] M. Grütter,et al. Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation. , 2009, Structure.
[7] Deborah H Anderson,et al. Caspase 8 Promotes Peripheral Localization and Activation of Rab5 , 2008, Journal of Biological Chemistry.
[8] Yu Xue,et al. GPS 2.0, a Tool to Predict Kinase-specific Phosphorylation Sites in Hierarchy *S , 2008, Molecular & Cellular Proteomics.
[9] S. Janssens,et al. Brief Definitive Report Stimulation of Toll-like Receptor 3 and 4 Induces Interleukin-1  Maturation by Caspase-8 , 2022 .
[10] D. Stupack,et al. Identification of a Critical Tyrosine Residue in Caspase 8 That Promotes Cell Migration* , 2008, Journal of Biological Chemistry.
[11] John C. Marshall,et al. Dynamic Regulation of Neutrophil Survival through Tyrosine Phosphorylation or Dephosphorylation of Caspase-8* , 2008, Journal of Biological Chemistry.
[12] S. Frisch,et al. Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. , 2007, Cancer research.
[13] K. Vuori,et al. Novel noncatalytic role for caspase-8 in promoting SRC-mediated adhesion and Erk signaling in neuroblastoma cells. , 2007, Cancer research.
[14] Mingyao Liu,et al. XB130, a Novel Adaptor Protein for Signal Transduction* , 2007, Journal of Biological Chemistry.
[15] R. Lotan,et al. Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry. , 2006, Cancer research.
[16] Dong Sun Kim,et al. Polymorphisms in the caspase-8 gene and the risk of lung cancer. , 2006, Cancer genetics and cytogenetics.
[17] G. Superti-Furga,et al. Src kinase phosphorylates Caspase‐8 on Tyr380: a novel mechanism of apoptosis suppression , 2006, The EMBO journal.
[18] K. Vuori,et al. Caspase-8 promotes cell motility and calpain activity under nonapoptotic conditions. , 2006, Cancer research.
[19] P. Krammer,et al. The role of CAP3 in CD95 signaling: new insights into the mechanism of procaspase-8 activation , 2006, Cell Death and Differentiation.
[20] S. Adam‐Klages,et al. The Fas-associated death domain protein/caspase-8/c-FLIP signaling pathway is involved in TNF-induced activation of ERK. , 2005, Experimental cell research.
[21] L. Salmena,et al. Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor , 2005, Science.
[22] W. Park,et al. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. , 2005, Cancer research.
[23] T. Boggon,et al. Structure and regulation of Src family kinases , 2004, Oncogene.
[24] G. Martin,et al. The road to Src , 2004, Oncogene.
[25] D. Kabelitz,et al. Caspase Inhibition Blocks Human T Cell Proliferation by Suppressing Appropriate Regulation of IL-2, CD25, and Cell Cycle-Associated Proteins1 , 2004, The Journal of Immunology.
[26] T. Kang,et al. Caspase-8 Serves Both Apoptotic and Nonapoptotic Roles1 , 2004, The Journal of Immunology.
[27] W. Park,et al. Inactivating mutations of caspase-8 gene in colorectal carcinomas. , 2003, Gastroenterology.
[28] D. Green,et al. A unified model for apical caspase activation. , 2003, Molecular cell.
[29] C. Briand,et al. Insights into the regulatory mechanism for caspase-8 activation. , 2003, Molecular cell.
[30] E. Avizienyte,et al. Elevated c-Src is linked to altered cell–matrix adhesion rather than proliferation in KM12C human colorectal cancer cells , 2002, British Journal of Cancer.
[31] Mingyao Liu,et al. Molecular cloning of actin filament-associated protein: a putative adaptor in stretch-induced Src activation. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[32] M. Frame,et al. Src in cancer: deregulation and consequences for cell behaviour. , 2002, Biochimica et biophysica acta.
[33] John D Minna,et al. Differential Inactivation of Caspase-8 in Lung Cancers , 2002, Cancer biology & therapy.
[34] P. Auberger,et al. Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation , 2001, Oncogene.
[35] Y. Shiratori,et al. Reduced C‐terminal Src kinase activity is correlated inversely with pp60c‐src activity in colorectal carcinoma , 2001, Cancer.
[36] Martin Gs. The hunting of the Src. , 2001 .
[37] M. Gishizky,et al. SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling , 2000, Molecular and Cellular Biology.
[38] T. Yeatman,et al. Role of Src expression and activation in human cancer , 2000, Oncogene.
[39] N. Hynes,et al. Tyrosine kinase signalling in breast cancer , 2000, Breast Cancer Research.
[40] Yoshihiro Nishioka,et al. Mutation of the SRC Gene in Endometrial Carcinoma , 2000, Japanese journal of cancer research : Gann.
[41] R. Sékaly,et al. Early Activation of Caspases during T Lymphocyte Stimulation Results in Selective Substrate Cleavage in Nonapoptotic Cells , 1999, The Journal of experimental medicine.
[42] J. Tschopp,et al. Caspase Activation Is Required for T Cell Proliferation , 1999, The Journal of experimental medicine.
[43] D. Schlaepfer,et al. Signaling through focal adhesion kinase. , 1999, Progress in biophysics and molecular biology.
[44] Y. Shiratori,et al. Reduced C‐terminal Src kinase (Csk) activities in hepatocellular carcinoma , 1999, Hepatology.
[45] Timothy J. Yeatman,et al. Activating SRC mutation in a subset of advanced human colon cancers , 1999, Nature Genetics.
[46] J. Blenis,et al. Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.
[47] V. Dixit,et al. Death receptors: signaling and modulation. , 1998, Science.
[48] J. Beckmann,et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.
[49] K. Matsumoto,et al. pp60c‐src Activation in hepatocellular carcinoma of humans and LEC rats , 1998, Hepatology.
[50] Matthias Mann,et al. FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC) , 1997, The EMBO journal.
[51] V. Dixit,et al. Fas-associated Death Domain Protein Interleukin-1β-converting Enzyme 2 (FLICE2), an ICE/Ced-3 Homologue, Is Proximally Involved in CD95- and p55-mediated Death Signaling* , 1997, The Journal of Biological Chemistry.
[52] J. Bertin,et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[53] S. Srinivasula,et al. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[54] S. Srinivasula,et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[55] T. Hunter,et al. Requirement for c-Src Catalytic Activity and the SH3 Domain in Platelet-derived Growth Factor BB and Epidermal Growth Factor Mitogenic Signaling* , 1996, The Journal of Biological Chemistry.
[56] S. Courtneidge,et al. The Src SH3 Domain Is Required for DNA Synthesis Induced by Platelet-derived Growth Factor and Epidermal Growth Factor* , 1996, The Journal of Biological Chemistry.
[57] David Wallach,et al. Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor–Induced Cell Death , 1996, Cell.
[58] Matthias Mann,et al. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.
[59] C. Cartwright,et al. Src activity increases and Yes activity decreases during mitosis of human colon carcinoma cells , 1995, Molecular and cellular biology.
[60] R. Pepperkok,et al. The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[61] I Nicoletti,et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.
[62] T. Kmiecik,et al. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation , 1987, Cell.
[63] H. Oppermann,et al. Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src). , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[64] Samir Guglani. Death , 1890, The Lancet.
[65] L. Salmena,et al. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. , 2005, Science.
[66] Peter F Thall,et al. Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. , 2003, Gynecologic oncology.
[67] A Krueger,et al. The active caspase-8 heterotetramer is formed at the CD95 DISC , 2003, Cell Death and Differentiation.